Insulin aspart, recombinant Subcutaneous and Sx1 Medicated Post-Operative System
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sx1 Medicated Post-Operative System and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: bacitracin / lidocaine / neomycin / polymyxin b topical
Brand name:
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Syeda
- Insulin aspart, recombinant Subcutaneous-Sylatron
- Insulin aspart, recombinant Subcutaneous-Sylvant
- Insulin aspart, recombinant Subcutaneous-Symax Duotab
- Insulin aspart, recombinant Subcutaneous-Symax FasTab
- Insulin aspart, recombinant Subcutaneous-Symax FasTabs
- Sx1 Medicated Post-Operative System-Insulin degludec
- Sx1 Medicated Post-Operative System-Insulin Degludec (U-100) Prefilled Pens
- Sx1 Medicated Post-Operative System-Insulin Degludec (U-100) Vials
- Sx1 Medicated Post-Operative System-Insulin Degludec (U-200) Prefilled Pens
- Sx1 Medicated Post-Operative System-Insulin degludec and liraglutide
- Sx1 Medicated Post-Operative System-Insulin degludec and liraglutide Subcutaneous